UTHR UNITED THERAPEUTICS Corp
Price Chart
Executive Summary
Three top insiders at United Therapeutics (CEO, CFO, General Counsel) sold a combined ~$110K in open-market transactions over two days. The dollar amount is trivial relative to the company's $24.1B market cap (~0.0005%) and is consistent with routine stock-for-tax settlements after option exercises. The cluster pattern is weak — these are small, liquidity-driven sales, not a coordinated signal of deteriorating fundamentals.
Key Financial Metrics
Actionable Insight
Traders should treat this as routine and non-informative. The sales represent a tiny fraction of each executive's holdings and are paired with option exercises, suggesting tax- or diversification-driven dispositions. No bearish signal from this cluster. Monitor next quarterly filing for any shift in business momentum, but this insider activity alone does not warrant action.
Key Facts
- CEO Martine Rothblatt sold 47 shares for $26K on May 22 (open-market).
- CFO James Edgemond sold 40 shares for $22K on May 21 (open-market).
- General Counsel Paul Mahon sold 110 shares for $61K on May 21 (open-market).
- All three also exercised non-cash stock options or derivative conversions in the same window.
- Total open-market sales = ~$110K, or 0.0005% of the $24.1B market cap.
- No insider open-market purchases were reported in the cluster.
Financial Impact
Approximately $110,000 in insider sales — immaterial relative to $24.1B market cap.
Risk Factors
- Insider sales are small and likely liquidity-driven, but any unexpected acceleration in selling volume or pattern change in future filings would warrant closer scrutiny.
- The company has no current known catalysts or disclosures that would explain insider selling — absence of red flags is not a guarantee of continued stock performance.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1779828428370 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
4d ago
|
Insider Cluster
| $544.59 awaiting T+1 | awaiting T+1 | — | $545.96 (+0.25%) |
|
Jun 9, 2026
5d ago
|
Insider Cluster
| $553.04 awaiting T+1 | awaiting T+1 | — | $545.96 (−1.28%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 4, 2026
10d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 4, 2026
10d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 3, 2026
11d ago
|
Insider Cluster
| $547.22 $546.37 | ▼ −0.16% | ▲ +2.44% | $545.96 (−0.23%) |
|
May 29, 2026
16d ago
|
Insider Cluster
| $544.45 $539.91 | ▼ −0.83% | ▼ −0.98% | $545.96 (+0.28%) |
|
May 28, 2026
17d ago
|
Insider Cluster
| $553.34 $544.45 | ▼ −1.61% | ▼ −1.86% | $545.96 (−1.33%) |
|
May 27, 2026
18d ago
|
Insider Cluster
| $561.70 $553.34 | ▼ −1.49% | ▼ −1.73% | $545.96 (−2.80%) |
|
May 26, 2026
19d ago
|
Insider Cluster
| $567.74 $561.70 | ▼ −1.06% | ▼ −1.62% | $545.96 (−3.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access